1 minute read

RISK-SHARING MODEL IN THE FACE OF HEALTH BUDGET CHALLENGES

Next Article
Family-Owned Pharma’s Drug Formulation a Difference Maker

Family-Owned Pharma’s Drug Formulation a Difference Maker

RISK-SHARING MODEL IN THE FACE OF HEALTH BUDGET CHALLENGES

ANA LONGORIA

President and General Director at Novartis

More articles from this publication:
This article is from:

Mexico Health Review 2018